These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 28939107)

  • 1. Elucidating structural and molecular mechanisms of β-arrestin-biased agonism at GPCRs via MS-based proteomics.
    Xiao K; Sun J
    Cell Signal; 2018 Jan; 41():56-64. PubMed ID: 28939107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct conformational changes in beta-arrestin report biased agonism at seven-transmembrane receptors.
    Shukla AK; Violin JD; Whalen EJ; Gesty-Palmer D; Shenoy SK; Lefkowitz RJ
    Proc Natl Acad Sci U S A; 2008 Jul; 105(29):9988-93. PubMed ID: 18621717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging structural insights into biased GPCR signaling.
    Shukla AK; Singh G; Ghosh E
    Trends Biochem Sci; 2014 Dec; 39(12):594-602. PubMed ID: 25458114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanism of β-arrestin-biased agonism at seven-transmembrane receptors.
    Reiter E; Ahn S; Shukla AK; Lefkowitz RJ
    Annu Rev Pharmacol Toxicol; 2012; 52():179-97. PubMed ID: 21942629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Mass Spectrometry-Based Structural Assay for Activation-Dependent Conformational Changes in β-Arrestins.
    Zhao Y; Xiao K
    Methods Mol Biol; 2019; 1957():293-308. PubMed ID: 30919361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G protein-coupled receptor kinases (GRKs) orchestrate biased agonism at the β
    Choi M; Staus DP; Wingler LM; Ahn S; Pani B; Capel WD; Lefkowitz RJ
    Sci Signal; 2018 Aug; 11(544):. PubMed ID: 30131371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening β-arrestin recruitment for the identification of natural ligands for orphan G-protein-coupled receptors.
    Southern C; Cook JM; Neetoo-Isseljee Z; Taylor DL; Kettleborough CA; Merritt A; Bassoni DL; Raab WJ; Quinn E; Wehrman TS; Davenport AP; Brown AJ; Green A; Wigglesworth MJ; Rees S
    J Biomol Screen; 2013 Jun; 18(5):599-609. PubMed ID: 23396314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct CCK-2 receptor conformations associated with β-arrestin-2 recruitment or phospholipase-C activation revealed by a biased antagonist.
    Magnan R; Escrieut C; Gigoux V; De K; Clerc P; Niu F; Azema J; Masri B; Cordomi A; Baltas M; Tikhonova IG; Fourmy D
    J Am Chem Soc; 2013 Feb; 135(7):2560-73. PubMed ID: 23323542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-arrestin-biased ligands at seven-transmembrane receptors.
    Violin JD; Lefkowitz RJ
    Trends Pharmacol Sci; 2007 Aug; 28(8):416-22. PubMed ID: 17644195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fulfilling the Promise of "Biased" G Protein-Coupled Receptor Agonism.
    Luttrell LM; Maudsley S; Bohn LM
    Mol Pharmacol; 2015 Sep; 88(3):579-88. PubMed ID: 26134495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Structural Insights into GPCR-β-Arrestin Interaction and Signaling.
    Ranjan R; Dwivedi H; Baidya M; Kumar M; Shukla AK
    Trends Cell Biol; 2017 Nov; 27(11):851-862. PubMed ID: 28651823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPCR systems pharmacology: a different perspective on the development of biased therapeutics.
    Eiger DS; Pham U; Gardner J; Hicks C; Rajagopal S
    Am J Physiol Cell Physiol; 2022 May; 322(5):C887-C895. PubMed ID: 35196164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric coupling and biased agonism in G protein-coupled receptors.
    Bock A; Bermudez M
    FEBS J; 2021 Apr; 288(8):2513-2528. PubMed ID: 33621418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity.
    Sanchez-Soto M; Verma RK; Willette BKA; Gonye EC; Moore AM; Moritz AE; Boateng CA; Yano H; Free RB; Shi L; Sibley DR
    Sci Signal; 2020 Feb; 13(617):. PubMed ID: 32019899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of β-arrestin-biased β
    Woo AY; Ge XY; Pan L; Xing G; Mo YM; Xing RJ; Li XR; Zhang YY; Wainer IW; Cheng MS; Xiao RP
    Acta Pharmacol Sin; 2019 Aug; 40(8):1095-1105. PubMed ID: 30643208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biased ligand modulation of seven transmembrane receptors (7TMRs): functional implications for drug discovery.
    Correll CC; McKittrick BA
    J Med Chem; 2014 Aug; 57(16):6887-96. PubMed ID: 24697360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biased signaling of G protein coupled receptors (GPCRs): Molecular determinants of GPCR/transducer selectivity and therapeutic potential.
    Seyedabadi M; Ghahremani MH; Albert PR
    Pharmacol Ther; 2019 Aug; 200():148-178. PubMed ID: 31075355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Systematic Approach to Identify Biased Agonists of the Apelin Receptor through High-Throughput Screening.
    McAnally D; Siddiquee K; Sharir H; Qi F; Phatak S; Li JL; Berg E; Fishman J; Smith L
    SLAS Discov; 2017 Aug; 22(7):867-878. PubMed ID: 28314120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FPR2 signaling without β-arrestin recruitment alters the functional repertoire of neutrophils.
    Gabl M; Holdfeldt A; Sundqvist M; Lomei J; Dahlgren C; Forsman H
    Biochem Pharmacol; 2017 Dec; 145():114-122. PubMed ID: 28855087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simulations of biased agonists in the β(2) adrenergic receptor with accelerated molecular dynamics.
    Tikhonova IG; Selvam B; Ivetac A; Wereszczynski J; McCammon JA
    Biochemistry; 2013 Aug; 52(33):5593-603. PubMed ID: 23879802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.